Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
10.01
0.30 (3.09%)
At close: Aug 15, 2025, 3:59 PM
10.05
0.40%
After-hours: Aug 15, 2025, 07:52 PM EDT
Niagen Bioscience Inc Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 17.73M | 14.11M | 8.55M | 1.49M | -1.35M | -3.53M | -4.94M | -6.47M | -6.5M | -10.7M | -16.54M | -20.45M | -28.32M | -27.49M | -27.13M | -27.9M | -23.26M | -21.4M |
Depreciation & Amortization | 1.45M | 1.46M | 1.48M | 1.5M | 1.58M | 1.66M | 1.71M | 1.79M | 1.79M | 1.77M | 1.88M | 1.82M | 1.78M | 1.77M | 1.63M | 1.63M | 1.59M | 1.55M |
Stock-Based Compensation | 4.05M | 3.75M | 3.66M | 3.94M | 4.32M | 4.46M | 4.75M | 5.04M | 5.15M | 5.12M | 5.74M | 5.89M | 6.48M | 6.8M | 6.2M | 6.5M | 6.25M | 6.35M |
Other Working Capital | 125K | -238K | 230K | -1.1M | -390K | 1.01M | 1.66M | 3.59M | -47K | -795K | -875K | -2.48M | 116K | -580K | -1.15M | 309K | 14K | 1.88M |
Other Non-Cash Items | -6.16M | -6.22M | -4.8M | 139K | 338K | 723K | 977K | 965K | 704K | 229K | -167K | -170K | -340K | -293K | -193K | 71K | 156K | 26K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.14M | 6.61M | 3.22M | -2.89M | -3.81M | 1.31M | 4.62M | 4.82M | 856K | -1.53M | -6.01M | -6.8M | -1.5M | -6.74M | -4.66M | 499K | -1.87M | 2.69M |
Operating Cash Flow | 21.21M | 19.7M | 12.11M | 4.17M | 1.08M | 4.62M | 7.12M | 6.14M | 2M | -5.11M | -15.1M | -19.71M | -21.89M | -25.96M | -24.16M | -19.2M | -17.12M | -10.78M |
Capital Expenditures | -277K | -154K | -163K | -115K | -100K | -98K | -148K | -299K | -325K | -400K | -334K | -164K | -208K | -388K | -409K | -384K | -346K | -173K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 20K | 20K | 20K | 20K | n/a | 5K | 5K | 5K | 5K | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -26K | -36K |
Investing Cash Flow | -257K | -134K | -143K | -95K | -100K | -93K | -143K | -294K | -320K | -400K | -334K | -164K | -208K | -388K | -409K | -391K | -354K | -191K |
Debt Repayment | -12K | -11K | -11K | -10K | -9K | -17K | -15K | -20K | -20K | -14K | -16K | -14K | -13K | -19K | -31K | -83K | -136K | -207K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -53K | -47K | -52K | -86K | -86K | -86K | -75K | -62K | -77K | -77K | -77K | 52K | 408K | 796K | 9.38M | 10.55M | 10.76M | 12.54M |
Financial Cash Flow | 11.63M | 8.49M | 5.37M | 1.54M | 503K | -103K | -90K | 7.67M | 7.65M | 7.66M | 7.65M | 38K | 395K | 2.65M | 36.09M | 37.21M | 37.37M | 42.06M |
Net Cash Flow | 32.59M | 28.05M | 17.34M | 5.63M | 1.48M | 4.42M | 6.88M | 13.51M | 9.33M | 2.15M | -7.78M | -19.84M | -21.71M | -23.7M | 11.52M | 17.62M | 19.89M | 31.08M |
Free Cash Flow | 20.93M | 19.54M | 11.95M | 4.06M | 976K | 4.52M | 6.97M | 5.84M | 1.68M | -5.51M | -15.43M | -19.88M | -22.1M | -26.34M | -24.57M | -19.58M | -17.47M | -10.96M |